Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Diawel 50
Diawel 50 (Diacerein 50 mg) is an advanced treatment for osteoarthritis, designed to relieve joint pain, reduce inflammation, and protect cartilage from further degeneration. Its unique mechanism of action differentiates it from conventional NSAIDs by specifically targeting interleukin-1β, a key factor in osteoarthritis progression.
Uses of Diawel 50
Management of osteoarthritis and degenerative joint diseases
Reduction of joint pain, stiffness, and swelling
Enhancement of joint mobility and function
Slowing down cartilage degradation
Benefits of Diawel 50
Selective anti-inflammatory action with fewer gastrointestinal side effects
Promotes cartilage repair and synthesis of essential joint components
Suitable for long-term osteoarthritis management
Delayed onset of action, reducing dependence on NSAIDs
Mechanism of Action of Diawel 50
Diawel 50 works by selectively inhibiting interleukin-1β, a pro-inflammatory cytokine that contributes to cartilage degradation and joint inflammation. By reducing the activity of IL-1β, Diacerein helps slow down osteoarthritis progression while promoting cartilage repair and joint function. Unlike NSAIDs, it does not interfere with prostaglandin synthesis, making it a safer option for long-term osteoarthritis management.